| Olaparib |
ENSG00000126005.11 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000153363.8 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000166770.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000170846.11 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000175873.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000177406.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000177993.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000178977.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000179818.9 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000179859.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000180139.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000181798.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000182057.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000182109.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000182165.13 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000182310.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000182310.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000182376.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000182404.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000184068.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000184324.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000188825.9 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000196553.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000197463.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000197989.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000198468.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000203307.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000203321.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000203327.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000203441.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000203499.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000203865.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000203875.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000204011.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000204603.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000204623.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000204625.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000204758.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000204792.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000204792.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000204815.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000205266.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000205488.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000206140.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000206176.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000206337.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000212552.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000213863.2 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000213904.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000213963.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000213971.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000214146.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000214559.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000214894.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000215304.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000215424.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000215866.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000218510.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000219665.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000222041.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000222043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000223393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000223401.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000223528.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000223576.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000223579.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000223675.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000223751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000223768.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000223804.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000223960.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000224017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000224020.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000224023.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000224032.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000224034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000224079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000224167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000224216.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000224222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000224271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000224292.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000224409.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000224460.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000224468.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000224490.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000224490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000224533.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000224596.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000224707.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000224750.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000224764.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000224799.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000224818.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000224818.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000224843.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000224843.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000224846.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000224875.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000224888.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000224888.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000224897.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000224939.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000224950.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000224950.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000224959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000224969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000224972.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000224992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000225000.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000225030.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000225037.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000225075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000225075.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000225075.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000225084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000225111.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000225163.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000225172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000225177.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000225278.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000225361.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000225383.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000225393.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000225408.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000225484.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000225541.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000225602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000225610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000225643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000225676.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000225703.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000225725.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000225760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000225762.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000225764.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000225778.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000225793.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000225822.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000225857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000225877.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000225891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000226009.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000226017.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000226044.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000226089.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000226091.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000226245.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000226251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000226263.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000226276.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000226328.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000226334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000226505.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000226669.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000226711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000226864.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000226869.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000226876.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000227050.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000227175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000227218.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000227220.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000227256.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000227258.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000227285.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000227354.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000227373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000227403.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000227486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000227495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000227517.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000227518.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000227542.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000227598.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000227603.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000227627.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000227627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000227726.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000227741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000227811.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000227811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000227877.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000227963.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000228016.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000228021.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000228067.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000228113.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000228124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000228140.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000228223.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000228251.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000228251.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000228293.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000228386.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000228395.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000228408.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000228540.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000228544.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000228554.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000228566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000228573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000228573.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000228624.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000228630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000228763.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000228775.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000228779.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000228824.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000228889.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000228933.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000228933.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000229043.2 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000229065.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000229160.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000229190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000229282.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000229463.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000229463.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000229583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000229645.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000229688.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000229780.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000229893.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000229950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000229952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000229983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000230013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000230013.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000230013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000230058.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000230102.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000230102.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000230107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000230184.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000230262.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000230310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000230415.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000230415.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000230424.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000230454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000230499.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000230537.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000230555.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000230696.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000230806.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000230815.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000230826.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000230836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000230844.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000230918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000231028.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000231028.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000231039.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000231102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000231119.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000231119.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000231193.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000231242.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000231291.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000231305.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000231365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000231365.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000231383.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000231401.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000231407.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000231486.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000231521.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000231609.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000231628.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000231636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000231764.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000231795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000231806.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000231858.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000231882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000231993.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000232019.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000232023.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000232151.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000232224.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000232284.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000232347.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000232352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000232377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000232462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000232480.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000232519.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000232527.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000232536.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000232623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000232642.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000232686.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000232719.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000232721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000232759.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000232874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000232884.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000232909.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000232969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000232995.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000233029.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000233030.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000233030.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000233030.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000233033.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000233058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000233060.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000233351.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000233396.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000233421.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000233452.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000233509.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000233509.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000233547.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000233590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000233593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000233651.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000233694.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000233723.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000233783.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000233799.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000233806.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000233844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000233847.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000233847.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000233862.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000233885.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000233926.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000234028.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000234174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000234183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000234183.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000234232.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000234245.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000234263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000234327.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000234396.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000234428.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000234432.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000234492.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000234571.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000234571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000234676.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000234695.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000234698.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000234705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000234707.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000234741.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000234913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000235091.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000235100.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000235100.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000235111.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000235146.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000235204.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000235204.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000235245.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000235246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000235313.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000235314.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000235314.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000235426.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000235461.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000235480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000235565.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000235565.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000235703.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000235706.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000235706.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000235724.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000235726.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000235760.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000235786.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000235802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000235834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000236051.2 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000236065.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000236088.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000236137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000236144.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000236209.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000236262.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000236269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000236333.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000236383.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000236423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000236514.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000236514.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000236535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000236536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000236558.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000236581.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000236605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000236618.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000236682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000236717.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000236743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000236751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000236799.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000236810.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000236889.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000237017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000237021.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000237073.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000237087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000237152.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000237187.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000237200.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000237310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000237356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000237357.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000237424.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000237461.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000237485.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000237489.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000237643.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000237689.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000237705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000237805.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000237845.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000237851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000237857.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000237903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000237927.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000237976.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000238045.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000238062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000238068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000238107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000238141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000238142.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000238171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000238266.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000238290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000239213.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000239219.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000239445.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000239462.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000239523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000239569.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000239636.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000239664.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000239911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000240211.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000240288.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000240498.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000240553.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000240766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000240770.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000241014.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000241505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000241599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000241764.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000241770.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000241860.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000242125.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000242242.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000242282.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000242375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000242553.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000243008.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000243055.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000243179.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000243220.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000243243.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000243368.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000243415.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000243485.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000243701.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000243902.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000244036.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000244124.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000244260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000244265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000244268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000244513.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000244733.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000244952.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000245080.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000245322.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000245322.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000245812.2 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000245928.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000245975.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000246273.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000246363.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000246523.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000246526.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000246548.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000246640.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000246792.2 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000246859.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000247092.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000247095.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000247516.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000247735.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000247735.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000247765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000247809.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000247925.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000247982.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000248079.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000248125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000248125.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000248161.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000248187.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000248254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000248268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000248275.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000248356.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000248367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000248367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000248416.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000248429.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000248544.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000248571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000248599.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000248599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000248668.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000248677.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000248724.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000248758.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000248866.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000248925.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000248968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000249084.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000249207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000249328.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000249378.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000249383.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000249532.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000249602.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000249602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000249664.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000249717.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000249738.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000249753.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000249807.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000249875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000250015.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000250057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000250073.2 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000250075.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000250081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000250116.2 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000250132.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000250167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000250220.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000250286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000250286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000250295.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000250538.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000250548.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000250582.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000250604.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000250682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000250682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000250697.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000250734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000250740.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000250751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000250820.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000250893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000250900.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000250934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000250938.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000250958.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000251072.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000251151.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000251221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000251365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000251381.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000251417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000251448.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000251460.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000251577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000251615.3 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000251629.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000251661.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000253116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000253121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000253121.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000253133.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000253167.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000253172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000253194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000253197.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000253214.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000253284.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000253298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000253374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000253392.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000253438.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000253476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000253476.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000253535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000253559.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000253582.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000253608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000253669.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000253730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000253737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000253746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000253773.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000253824.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000253893.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000253929.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000253986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000254154.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000254231.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000254258.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000254258.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000254319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000254338.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000254340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000254396.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000254428.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000254433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000254459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000254468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000254477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000254480.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000254561.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000254602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000254639.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000254791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000254860.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000254910.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000254934.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000254964.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000255008.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000255052.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000255135.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000255153.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000255153.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000255158.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000255158.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000255176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000255237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000255241.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000255247.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000255299.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000255306.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255320.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000255328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000255337.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000255355.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000255367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255455.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000255509.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000255557.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000255557.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000255571.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255723.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000255741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000255760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000255772.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000255775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000255867.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000255968.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000255970.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000256325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000256433.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000256448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000256458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000256582.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000256588.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000256588.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000256705.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000256712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000256746.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000256747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000256789.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000257027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000257038.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000257176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000257176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000257176.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000257261.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000257270.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000257277.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000257391.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000257433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000257497.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000257527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000257556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000257557.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000257642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000257660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000257681.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000257740.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000257759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000257859.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000257910.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000257913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000258001.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000258010.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000258101.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000258101.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000258188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000258199.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000258355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000258378.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000258413.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000258454.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000258461.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000258520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000258520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000258545.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000258620.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000258623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000258623.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000258693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000258711.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000258731.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000258789.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000258808.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000258809.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000258815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000258857.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000258858.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000258922.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000258935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000258935.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000258935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000258959.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000258999.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000259036.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259146.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259182.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000259215.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000259215.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259242.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259244.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259245.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259254.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259275.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000259287.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259345.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000259347.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259408.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259422.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000259422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259437.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259448.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000259536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000259551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259553.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000259563.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000259577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259579.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000259583.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000259617.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000259623.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000259645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259715.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259762.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259782.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000259810.2 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000259818.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000259854.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000259901.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000259901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000259921.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000259953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000260000.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260000.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000260051.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000260059.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000260083.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260083.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000260083.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000260141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000260160.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260167.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260173.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000260177.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260190.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260219.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260260.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260269.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000260279.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260331.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000260349.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260394.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000260409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000260418.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260493.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260526.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260579.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260581.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260588.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000260589.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000260593.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260601.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000260647.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000260693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000260704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000260742.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000260757.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000260774.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260790.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260793.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000260796.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260814.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000260830.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260853.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260876.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260876.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000260884.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000260898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000260907.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000260917.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000260932.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000260938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000260938.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000260938.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000260941.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000260949.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000260954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000260954.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000260977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000260988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000261015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000261024.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000261068.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000261087.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000261131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000261168.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000261173.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000261183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000261183.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000261183.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000261189.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000261200.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000261204.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000261204.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000261252.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000261280.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000261318.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000261353.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000261357.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000261372.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000261396.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000261416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000261434.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000261437.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000261442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000261455.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000261465.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000261468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000261478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000261488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000261488.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000261519.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000261584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000261589.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000261600.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000261610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000261616.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000261695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000261730.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000261766.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000261766.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000261783.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000261790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000261798.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000261804.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000261827.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000261839.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000261840.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000261925.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000262094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000262151.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000262155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000262185.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000262298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000262410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000262482.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000262663.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000262681.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000262692.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000262693.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000262714.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000262721.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000262772.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000262877.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000262877.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000262879.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000262921.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000262921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000262951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000262979.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000263063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000263069.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000263105.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000263300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000263300.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000263300.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000263350.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000263370.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000263470.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000263531.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000263709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000263862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000263874.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000263916.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000264107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000264125.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000264290.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000264290.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000264339.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000264448.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000264456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000264456.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000264577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000264577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000264608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000264635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000264808.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000264853.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000264853.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000264860.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000265094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000265094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000265334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000265342.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000265458.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000265728.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000265728.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000265791.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000265888.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000266010.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000266088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000266126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000266126.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000266283.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000266651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000266667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000266783.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000266783.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000266821.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000266824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000266824.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000266830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000266904.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000266912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000266921.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000266933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000266934.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000266947.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000266965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000266975.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000266975.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000266994.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000266994.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000267003.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000267006.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000267009.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000267026.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000267034.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000267047.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000267063.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267064.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267067.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000267067.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000267089.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267093.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000267123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000267128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000267130.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000267130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000267151.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000267152.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000267169.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000267201.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000267249.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000267263.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000267265.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000267277.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267279.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000267282.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000267296.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000267298.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000267299.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000267311.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000267321.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267394.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000267395.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000267412.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000267414.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000267421.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000267470.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000267474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000267522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000267546.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267560.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000267581.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000267658.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000267666.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267705.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000267729.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000267730.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000267734.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000267743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000267750.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000267750.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000267762.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267764.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000267776.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000267808.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000267834.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000267904.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000267939.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000268001.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000268027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000268087.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000268157.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000268186.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000268189.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000268257.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000268257.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000268392.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000268401.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000268543.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000268584.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000268670.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000268743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000268756.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000268889.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000268912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000268912.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000268938.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000269054.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000269102.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000269107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000269191.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000269191.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000269235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000269293.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000269321.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000269352.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000269387.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000269427.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000269439.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000269486.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000269486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000269574.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000269609.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000269814.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000269826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000269903.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000269916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000269921.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000269929.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000269946.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000269949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000269959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000269973.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000269974.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000269983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000269994.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000269996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000270000.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000270006.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000270019.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000270030.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000270048.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000270068.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000270103.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000270108.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000270115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000270145.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000270154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000270168.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000270190.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000270190.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000270361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000270457.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000270462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000270557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000270557.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000270607.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000270792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000270876.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000270949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000270964.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000270996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000270996.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000271032.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000271172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000271172.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000271384.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000271551.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000271576.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000271576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000271593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000271631.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000271716.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000271742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000271752.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000271752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000271771.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000271826.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000271833.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000271855.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000271862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000271882.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000271904.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000271911.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000271914.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000271926.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000271967.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000271967.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000271975.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000271991.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272048.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000272071.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000272097.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272121.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000272138.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000272138.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000272180.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000272216.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000272216.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000272221.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000272248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000272250.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000272250.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000272254.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000272273.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000272312.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000272346.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000272354.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000272361.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000272366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000272368.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000272369.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000272386.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272411.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000272417.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000272425.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000272462.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272529.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000272558.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272564.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000272574.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000272583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000272604.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000272669.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000272702.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000272716.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000272719.1 |
Predicted lncRNA |
Sarcoma |
|
| Olaparib |
ENSG00000272734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000272760.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000272787.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000272810.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272815.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000272885.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272885.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000272885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000272904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000272905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000272905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000272917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000272945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000272945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000272949.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000272950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000272971.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000273007.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000273015.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000273038.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000273076.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000273102.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000273137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000273139.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000273143.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000273188.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000273209.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000273230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000273245.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000273249.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
ENSG00000273249.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Olaparib |
ENSG00000273297.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000273311.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000273338.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Olaparib |
ENSG00000273353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000273365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000273367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Olaparib |
ENSG00000273381.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000273415.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Olaparib |
ENSG00000273432.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Olaparib |
ENSG00000273473.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000273474.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Olaparib |
ENSG00000273476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Olaparib |
ENSG00000273483.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Olaparib |
hsa-let-7a-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-let-7b-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-let-7c |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-101-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-106a-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-127-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-136-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-137 |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-148b-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-152 |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-154-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-17-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-18a-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-18b-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-19a-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-19b-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-204-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-20a-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-20b-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-22-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-23b-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-24-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-27a-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-27b-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-28-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-299-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-301a-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-32-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-324-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-329-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-330-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-337-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-376a-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-376b-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-376c-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-377-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-378a-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-379-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-381-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-382-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-409-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-425-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-493-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-495-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-539-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-543 |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-654-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-663a |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-7-5p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-758-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
hsa-miR-92a-3p |
predicted miRNA |
NCI60 |
|
| Olaparib |
miR-103 |
Curated miRNA |
- |
|
| Olaparib |
miR-107 |
Curated miRNA |
- |
|
| Olaparib |
miR-182 |
Curated miRNA |
breast cancer |
|
| Olaparib |
miR-506 |
Curated miRNA |
ovarian cancer |
|
| Olaparib |
miR-96 |
Curated miRNA |
cancer |
|
| Olaparib |
PCAT-1 |
Curated lncRNA |
prostate cancer |
|